The content is available as a PDF (754.6 KB).
. 2004 Apr 15;17(3):213–222. doi: 10.1016/0092-1157(89)90013-9
Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man
Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy
Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy
Issue date 1989.
Copyright © 1989 Published by Elsevier Ltd.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC7133254 PMID: 2793873